Call Us: 1.800.873.5297

By

TVM Update: $5.7 Million Jury Verdict Against Johnson & Johnson in California Transvaginal Mesh Case

According to Reuters, yet another jury has returned a multi-million dollar award against Johnson & Johnson in a vaginal mesh lawsuit. In the latest of a series of trials, a California state jury sitting in Kern County awarded a $5.7 million verdict against Johnson & Johnson and its subsidiary Ethicon for complications with Ethicon’s Gynecare TVT […]

By

According to Expert in Philadelphia State Court Case, Actos Largest Bladder Cancer Risk for Plaintiff

Law 360 reports that setting aside a history of smoking and other risk factors, an expert witness told a jury in Philadelphia that the most significant contributing factor for the retired western Pennsylvania teacher, who was diagnosed with bladder cancer in 2008, was his long-term Actos use. University of Colorado oncologist and bladder cancer specialist […]

By

TVM MDL Update (MDL 2187): C.R. Bard Transvaginal Mesh Litigation Moves Forward

On December 17, 2014, Judge Joseph Goodwin, the federal judge overseeing the C.R. Bard Multidistrict Litigation (MDL 2187) in West Virginia, issued an order designating sixty (60) transvaginal mesh (TVM) cases involving the manufacturer C.R. Bard as ‘Miniwave 1’ cases. Per a previous order issued by the Court on December 10, 2014, these cases will […]

By

Transvaginal Mesh (MDL 2326) Update: Cases Against Boston Scientific Move Forward After First Two Bellwether Trials

Cases against Boston Scientific continue to move forward in the Multidistrict Litigation (In re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL 2326) before The Honorable Judge Joseph R. Goodwin in the United States District Court for the Southern District of West Virginia. According to the Court’s most recent Pretrial Order, new deadlines […]

By

TVM Lawsuit Update (MDL 2326): Boston Scientific Ordered by Jury to Pay $18.5 Million in Second Federal Trial

For the second time this month, Boston Scientific has been found liable by a jury in federal court for selling defective vaginal mesh implants, according to the Chicago Tribune. A jury in West Virginia federal court deliberated for six hours before concluding that Boston Scientific failed to adequately warn the four women at issue and […]

By

Actos® MDL Update: $9B Jury Verdict Against Takeda & Eli Lilly in First Actos MDL Trial Reduced to $36.8M

Law360 reports that the jury verdict of $9 billion in punitive damages against Takeda and Eli Lilly over the type II diabetes drug, Actos®, in the first federal trial has been reduced to $36.8 million. In particular, Judge Doherty ruled that although the verdict was not unreasonable, the jury “should bow” to the Constitution’s due […]

By

Transvaginal Mesh Manufacturer Boston Scientific Sets Aside Nearly $1 Billion for Legal Expenses

In light of the ongoing lawsuits against Boston Scientific on behalf of women alleging severe injuries from their transvaginal mesh (TVM) devices, the 2006 acquisition of Guidant Corporation, and IRS tax issues, Boston Scientific has set aside nearly $1 Billion to pay legal expenses – as reported by the Boston Business Journal. According to the […]

By

Actos Lawsuit Update: Verdict in Favor of Takeda in Las Vegas State Court

On May 22, 2014, a Las Vegas state court jury rendered a verdict in favor of Takeda Pharmaceuticals in a case involving two women who ingested the diabetes drug Actos®. Together, Plaintiffs Bertha Triana and Delores Cipriano sought over $56 million in compensatory damages.  The women claimed that Takeda failed to warn them and their […]

By

TVM Lawsuit Update: 1.2 Million Verdict Against Johnson & Johnson’s Ethicon® Transvaginal Mesh

Bloomberg reports that a Texas jury has rendered a verdict in favor of a woman who alleged one of the company’s Ethicon® transvaginal mesh products was defectively designed and caused her injuries. The jury ordered the manufacturer of the transvaginal mesh product, Johnson & Johnson, to pay $1.2 million dollars in damages. The Texas case […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.